How Far Are We from Visceral Leishmaniasis Elimination in Bangladesh? An Assessment of Epidemiological Surveillance Data

PLoS Neglected Tropical Diseases

Volumn 8, Issue 8, 2014, Pages

  Chowdhury, Rajib ^a   Mondal, Dinesh ^b   Chowdhury, Vashkar ^c   Faria, Shyla ^a   Alvar, Jorge ^d   Nabi, Shah Golam ^e   Boelaert, Marleen ^f   Dash, Aditya Prasad ^g  

^a National Institute of Preventive and Social Medicine   (Bangladesh)

^b INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^c Dhaka College   (Bangladesh)

^d DNDi ^*  (Switzerland)

^e Directorate General of Health Service (DGHS)   (Bangladesh)

^f INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^g NATIONAL INSTITUTE OF MALARIA RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANTIINFECTIVE AGENT; MILTEFOSIN; STIBOGLUCONATE SODIUM; UNCLASSIFIED DRUG;

BANGLADESH; DISEASE ELIMINATION; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; HEALTH SERVICE; HUMAN; PARASITE INCIDENCE; REVIEW; VISCERAL LEISHMANIASIS; LEISHMANIASIS, VISCERAL; TIME;

BANGLADESH; HUMANS; LEISHMANIASIS, VISCERAL; TIME FACTORS;

EID: 84928904103     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0003020     Document Type: Review

References (16)

1. Ahluwalia IB, Bern C, Costa C, Akter T, Chowdhury R, et al. (2003) Visceral Leishmaniasis: Consequences of neglected disease in a Bangladeshi community. Am J Trop Med Hyg 69: 624–628.
2. Alvar A, Velez ID, Bern C, Herrero M, Desjeux P, et al. (2012) Leishmaniasis Worldwide and Global Estimates of Its Incidence. PLoS ONE 7: e35671 doi:10.1371/journal.pone.0035671
3. Bern C, Chowdhury R, (2006) The epidemiology of visceral leishmaniasis in Bangladesh and prospects for improved control. Indian J Med Res 123: 275–288.
4. Mackie FP, (1914) Kala-Azar in Nowgong (Assam). Indian J Med Res 1: 626–662.
5. Dye C, Wolpert DM, (1998) Earthquakes, influenza and cycles of Indian kala-azar. Trans R Soc Trop Med Hyg 82: 843–850.
6. Sengupta PC, (1947) History of kala-azar in India. Indian Med Gazette 82: 281–286.
7. Sengupta PC, (1944) Kala-azar in Bengal: its incidence and trends. Indian Med Gazette 79: 547–552.
8. Rahman KM, Islam N, (1983) Resurgence of visceral leishmaniasis in Bangladesh. Bull World Health Organ 61: 113–116.
9. WHO (2005) Regional Strategic Framework for Elimination of Kala-azar from South East Asia Region (2005–2015). New Delhi: WHO.
10. WHO Regional Office for South-East Asia (2012) Department of Communicable Diseases: Profile and Vision. CDS Department. New Delhi: WHO. pp xii, 89.
11. Anoopa Sharma D, Bern C, Varghese B, Chowdhury R, Haque R, et al. (2006) The economic impact of visceral leishmaniasis on households in Bangladesh. Trop Med Int Health 11: 757–764.
12. Mondal D, Alam S, Karim Z, Haque R, Boelaert M, et al. (2008) Present situation of vector control in Bangladesh: a wake up call. Health Policy 87: 369–376.
13. Dorlo TPC, Eggelte TA, Schoone GJ, de Vries PJ, Beijnen JH, (2012) A Poor-Quality Generic Drug for the Treatment of Visceral Leishmaniasis: A Case Report and Appeal. PLoS Negl Trop Dis 6: e1544 doi:10.1371/journal.pntd.0001544
14. Ahluwalia IB, Bern C, Wagatsuma Y, Costa C, Chowdhury R, et al. (2004) Visceral Leishmaniasis: Consequences to Women in a Bangladeshi Community. J Womens Health (Larchmt) 13: 360–364.
15. Islam S, Kenah E, Bhuiyan MA, Rahman KM, Goodhew B, et al. (2013) Clinical and immunological aspects of post-kala-azar dermal leishmaniasis in Bangladesh. Am J Trop Med Hyg 89: 345–353 doi:10.4269/ajtmh.12-0711
16. Mondal D, Nasrin KN, Huda MM, Kabir M, Hossain MS, et al. (2010) Enhanced case detection and improved diagnosis of PKDL in a Kala-azar-endemic area of Bangladesh. PLoS Negl Trop Dis 4: e832 doi:10.1371/journal.pntd.0000832